Short-Term Effect of Intermittent Intrapulmonary Deflation on Air Trapping in Patients With COPD

REFERENCES

1. 1.↵
   1. Gagnon P,
   2. Guenette JA,
   3. Langer D,
   4. Laviolette L,
   5. Mainguy V,
   6. Maltais F,
   7. et al

   . Pathogenesis of hyperinflation in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2014;9:187-201.

   OpenUrlPubMed
2. 2.↵
   1. O'Donnell DE,
   2. Laveneziana P

   . Physiology and consequences of lung hyperinflation in COPD. Eur Respir Rev 2006;15(100):61-67.

   OpenUrlAbstract/FREE Full Text
3. 3.↵
   1. Fagevik Olsen M,
   2. Westerdahl E

   . Positive expiratory pressure in patients with chronic obstructive pulmonary disease–a systematic review. Respiration 2009;77(1):110-118.

   OpenUrlCrossRefPubMed
4. 4.↵
   1. Fagevik Olsén M,
   2. Lannefors L,
   3. Westerdahl E

   . Positive expiratory pressure - common clinical applications and physiological effects. Respir Med 2015;109(3):297-307.

   OpenUrlCrossRefPubMed
5. 5.↵
   1. Clini E

   . Positive expiratory pressure techniques in respiratory patients: old evidence and new insights. Breathe 2009;6(2):153-159.

   OpenUrlAbstract/FREE Full Text
6. 6.↵
   1. Myers TR

   . Positive expiratory pressure and oscillatory positive expiratory pressure therapies. Respir Care 2007;52(10):1308-1326; discussion 1327.

   OpenUrlAbstract/FREE Full Text
7. 7.↵
   1. Walicka-Serzysko K,
   2. Postek M,
   3. Jeneralska N,
   4. Cichocka A,
   5. Milczewska J,
   6. Sands D

   . ePS3.09 The effect of chest physiotherapy with the Simeox airway clearance technology in the treatment of cystic fibrosis pulmonary exacerbation - open-label study. J Cystic Fibrosis 2019;18:S46-S47.

   OpenUrl
8. 8.↵
   1. Bonnevie T,
   2. Elkins M,
   3. Paumier C,
   4. Medrinal C,
   5. Combret Y,
   6. Patout M,
   7. et al

   . Nasal high flow for stable patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. COPD 2019;16(5-6):368-377.

   OpenUrl
9. 9.↵
   1. Agusti A,
   2. Beasley R,
   3. Celli BR,
   4. Chen R,
   5. Criner G,
   6. Halpin D,
   7. et al

   . Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. 2022.
10. 10.↵
    1. Miller MR,
    2. Hankinson J,
    3. Brusasco V,
    4. Burgos F,
    5. Casaburi R,
    6. Coates A,
    7. et al

    ; ATS/ERS Task Force. Standardisation of lung function testing. Eur Respir J 2005;26(2):319-338.

    OpenUrlAbstract/FREE Full Text
11. 11.
    1. Wanger J,
    2. Clausen JL,
    3. Coates A,
    4. Pedersen OF,
    5. Brusasco V,
    6. Burgos F,
    7. et al

    . Standardisation of the measurement of lung volumes. Eur Respir J 2005;26(3):511-522.

    OpenUrlAbstract/FREE Full Text
12. 12.↵
    1. Borg GA

    . Psychophysical bases of perceived exertion. Med Sci Sports Exerc 1982;14(5):377-381.

    OpenUrlCrossRefPubMedWeb of Science
13. 13.↵
    1. Reychler G,
    2. Uribe Rodriguez V,
    3. Hickmann CE,
    4. Tombal B,
    5. Laterre PF,
    6. Feyaerts A,
    7. Roeseler J

    . Incentive spirometry and positive expiratory pressure improve ventilation and recruitment in postoperative recovery: a randomized crossover study. Physiother Theory Pract 2019;35(3):199-205.

    OpenUrl
14. 14.↵
    1. Lobo B,
    2. Hermosa C,
    3. Abella A,
    4. Gordo F

    . Electrical impedance tomography. Ann Transl Med 2018;6(2):26.

    OpenUrl
15. 15.
    1. Milne S,
    2. Huvanandana J,
    3. Nguyen C,
    4. Duncan JM,
    5. Chapman DG,
    6. Tonga KO,
    7. et al

    . Time-based pulmonary features from electrical impedance tomography demonstrate ventilation heterogeneity in chronic obstructive pulmonary disease. J Appl Physiol (1985) 2019;127(5):1441-1452.

    OpenUrl
16. 16.↵
    1. Zhang C,
    2. Dai M,
    3. Liu W,
    4. Bai X,
    5. Wu J,
    6. Xu C,
    7. et al

    . Global and regional degree of obstruction determined by electrical impedance tomography in patients with obstructive ventilatory defect. PloS One 2018;13(12):e0209473.

    OpenUrl
17. 17.↵
    1. Hinz J,
    2. Hahn G,
    3. Neumann P,
    4. Sydow M,
    5. Mohrenweiser P,
    6. Hellige G,
    7. Burchardi H

    . End-expiratory lung impedance change enables bedside monitoring of end-expiratory lung volume change. Intensive Care Med 2003;29(1):37-43.

    OpenUrlPubMedWeb of Science
18. 18.↵
    1. O'Donnell DE,
    2. Hernandez P,
    3. Kaplan A,
    4. Aaron S,
    5. Bourbeau J,
    6. Marciniuk D,
    7. et al

    . Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2008 update - highlights for primary care. Can Respir J 2008;15 Suppl A(Suppl A):1A-8A.

    OpenUrlCrossRefPubMedWeb of Science
19. 19.↵
    1. Cleophas TJ

    1. Cleophas TJ

    . Carryover effects in clinical research. In: Cleophas TJ, ed. Human Experimentation: Methodologic Issues Fundamental to Clinical Trials. Dordrecht: Springer Netherlands; 1999:25-36.
20. 20.↵
    1. Sherwood L

    . Human Physiology. 3rd edition. Louvain-la-Neuve, Belgium, Deboeck 2015;3:590.

    OpenUrl
21. 21.↵
    1. Zach MS

    . The physiology of forced expiration. Paediatr Respir Rev 2000;1(1):36-39.

    OpenUrlCrossRefPubMed
22. 22.↵
    1. West JB

    . Pulmonary Pathophysiology. 8th ed. Williams and Wilkins, Baltimore, 1978:227.
23. 23.↵
    1. Reychler G,
    2. Roeseler J,
    3. Delguste P

    . Kinésithérapie Respiratoire. 3th ed. Respiratory Physiotherapy: Paris. Elsevier Masson; 2009:384.
24. 24.↵
    1. Giovannetti P,
    2. Morin L,
    3. Lafforgue O,
    4. Poncet S,
    5. Favier J,
    6. Reynaud-Gaubert M

    . SIMETOL study: evaluation of the tolerance and efficacy of an innovative Simeox-assisted bronchial drainage procedure in cystic fibrosis as an alternative to conventional conventional respiratory physiotherapy. Revue Des Maladies Respiratoires 2019;36:A22.

    OpenUrl
25. 25.↵
    1. Groth S,
    2. Stafanger G,
    3. Dirksen H,
    4. Andersen JB,
    5. Falk M,
    6. Kelstrup M

    . Positive expiratory pressure (PEP-mask) physiotherapy improves ventilation and reduces volume of trapped gas in cystic fibrosis. Bull Eur Physiopathol Respir 1985;21(4):339-343.

    OpenUrlPubMedWeb of Science
26. 26.↵
    1. Liverani B,
    2. Nava S,
    3. Polastri M

    . An integrative review on the positive expiratory pressure (PEP)-bottle therapy for patients with pulmonary diseases. Physiother Res Int 2020;25(1):e1823.

    OpenUrl
27. 27.↵
    1. Rossi A,
    2. Aisanov Z,
    3. Avdeev S,
    4. Di Maria G,
    5. Donner CF,
    6. Izquierdo JL,
    7. et al

    . Mechanisms, assessment and therapeutic implications of lung hyperinflation in COPD. Respir Med 2015;109(7):785-802.

    OpenUrlPubMed
28. 28.↵
    1. Gibson GJ

    . Clinical Tests of Respiratory Function: Raven Press; London. 1984:334.
29. 29.↵
    1. Pereira CAC,
    2. Moreira MAF

    . Plethysmography - airway resistance. J Pneumol; 28:139-150.
30. 30.↵
    1. van Hengstum M,
    2. Festen J,
    3. Beurskens C,
    4. Hankel M,
    5. van den Broek W,
    6. Buijs W,
    7. Corstens F

    . The effect of positive expiratory pressure versus forced expiration technique on tracheobronchial clearance in chronic bronchitics. Scand J Gastroenterol Suppl 1988;143:114-118.

    OpenUrlPubMed
31. 31.
    1. van Winden CM,
    2. Visser A,
    3. Hop W,
    4. Sterk PJ,
    5. Beckers S,
    6. de Jongste JC

    . Effects of flutter and PEP mask physiotherapy on symptoms and lung function in children with cystic fibrosis. Eur Respir J 1998;12(1):143-147.

    OpenUrlAbstract/FREE Full Text
32. 32.↵
    1. Gastaldi AC,
    2. Paredi P,
    3. Talwar A,
    4. Meah S,
    5. Barnes PJ,
    6. Usmani OS

    . Oscillating positive expiratory pressure on respiratory resistance in chronic obstructive pulmonary disease with a small amount of secretion: a randomized clinical trial. Medicine (Baltimore) 2015;94(42):e1845.

    OpenUrl
33. 33.↵
    1. Gass R,
    2. Merola P,
    3. Monteiro MB,
    4. Cardoso DM,
    5. Paiva DN,
    6. Teixeira PJ,
    7. et al

    . Effects of expiratory positive airway pressure on exercise tolerance, dynamic hyperinflation, and dyspnea in COPD. Respir Care 2017;62(10):1298-1306.

    OpenUrlAbstract/FREE Full Text
34. 34.
    1. Cardoso DM,
    2. Gass R,
    3. Sbruzzi G,
    4. Berton DC,
    5. Knorst MM

    . Effect of the expiratory positive airway pressure on dynamic hyperinflation and exercise capacity in patients with COPD: a meta-analysis. Sci Rep 2020;10(1):13292.

    OpenUrl
35. 35.
    1. Nicolini A,
    2. Merliak F,
    3. Barlascini C

    . Use of positive expiratory pressure during six minute walk test: results in patients with moderate to severe chronic obstructive pulmonary disease. Multidiscip Respir Med 2013;8(1):19.

    OpenUrlPubMed
36. 36.↵
    1. Ubolsakka-Jones C,
    2. Pongpanit K,
    3. Boonsawat W,
    4. Jones DA

    . Positive expiratory pressure breathing speeds recovery of postexercise dyspnea in chronic obstructive pulmonary disease. Physiother Res Int 2019;24(1):e1750.

    OpenUrl
37. 37.↵
    1. Nicolini A,
    2. Mascardi V,
    3. Grecchi B,
    4. Ferrari-Bravo M,
    5. Banfi P,
    6. Barlascini C

    . Comparison of effectiveness of temporary positive expiratory pressure versus oscillatory positive expiratory pressure in severe COPD patients. Clin Respir J 2018;12(3):1274-1282.

    OpenUrlPubMed
38. 38.↵
    1. Nicolini A,
    2. Mollar E,
    3. Grecchi B,
    4. Landucci N

    . Comparison of intermittent positive pressure breathing and temporary positive expiratory pressure in patients with severe chronic obstructive pulmonary disease. Arch Bronconeumol 2014;50(1):18-24.

    OpenUrl
39. 39.↵
    1. Su C-L,
    2. Chiang L-L,
    3. Chiang T-Y,
    4. Yu C-T,
    5. Kuo H-P,
    6. Lin H-C

    . Domiciliary positive expiratory pressure improves pulmonary function and exercise capacity in patients with chronic obstructive pulmonary disease. J Formos Med Assoc 2007;106(3):204-211.

    OpenUrlPubMed
40. 40.↵
    1. Radtke T,
    2. Böni L,
    3. Bohnacker P,
    4. Maggi-Beba M,
    5. Fischer P,
    6. Kriemler S,
    7. et al

    . Acute effects of combined exercise and oscillatory positive expiratory pressure therapy on sputum properties and lung diffusing capacity in cystic fibrosis: a randomized, controlled, crossover trial. BMC Pulm Med 2018;18(1):99.

    OpenUrl